S.F. Teunissen

Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry

S.F. Teunissen, Nynke G L Jager, Hilde Rosing et al. · Journal of Chromatography B · 2011 · 61 citations

Pharmacy, Biochemistry, Pharmacology +17

Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry

S.F. Teunissen, Hilde Rosing, Rutger H.T. Koornstra et al. · Journal of Chromatography B · 2009 · 52 citations

Life Sciences, Biochemistry, Pharmacology +17

Development and validation of a liquid chromatography–tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma, urine, bile, intestinal contents, faeces and eight selected tissues from mice

S.F. Teunissen, Maria L.H. Vlaming, Hilde Rosing et al. · Journal of Chromatography B · 2010 · 17 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

ABC transporters Mdr1a/1b, Bcrp1, Mrp2 and Mrp3 determine the sensitivity to PhIP/DSS-induced colon carcinogenesis and inflammation

Selvi Durmuş, Martin van der Valk, S.F. Teunissen et al. · Archives of Toxicology · 2019 · 11 citations

Medicine, Oncology, Pharmacology +12